ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 028,28
1,13%
Dow Jones
41 488,19
1,65%
DAX
22 986,82
2,01%
Brent Oil
70,285
0,00%
Bitcoin
84 086,93
-0,31%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Adagio Therapeutics Inc (ADGI) Cours

Adagio Therapeutics Inc

Adagio Therapeutics Inc (ADGI)

NASDAQ
4,64
0,00
(0,00%)
Fermé 16 Mars 9:00PM
Retardé de 15 minutes
0,00
0,00
(0,00%)
Après les heures de négociation: -
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
4,64
Prix Achat
4,52
Prix Vente
4,74
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Cap du marché
510,934M
Clôture Veille
4,64
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
-
Actions en circulation
110 115 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-2,57
Bénéfice par action (BPA)
-1,8
Chiffre d'affairess
-
Bénéfice net
-198,64M

À propos de Adagio Therapeutics Inc

Adagio Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company's lead product candidate, ADG20 is developed for the treatment and preven... Adagio Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company's lead product candidate, ADG20 is developed for the treatment and prevention of coronavirus disease 2019, or COVID-19, the disease caused by the virus SARS-CoV-2 and its variants. Show more

Secteur
Biological Pds,ex Diagnstics
Industrie
Biological Pds,ex Diagnstics
Site Web
invivyd.com
Siège social
Wilmington, Delaware, USA
Fondé
-

ADGI Dernières nouvelles

Plus de nouvelles
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

ADGI - Frequently Asked Questions (FAQ)

What is the current Adagio Therapeutics share price?
The current share price of Adagio Therapeutics is US$ 4,64
How many Adagio Therapeutics shares are in issue?
Adagio Therapeutics has 110 115 000 shares in issue
What is the market cap of Adagio Therapeutics?
The market capitalisation of Adagio Therapeutics is USD 510,93M
What is the 1 year trading range for Adagio Therapeutics share price?
Adagio Therapeutics has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the PE ratio of Adagio Therapeutics?
The price to earnings ratio of Adagio Therapeutics is -2,57
What is the reporting currency for Adagio Therapeutics?
Adagio Therapeutics reports financial results in USD
What is the latest annual profit for Adagio Therapeutics?
The latest annual profit of Adagio Therapeutics is USD -198,64M
What is the registered address of Adagio Therapeutics?
The registered address for Adagio Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE ST, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Adagio Therapeutics website address?
The website address for Adagio Therapeutics is invivyd.com
Which industry sector does Adagio Therapeutics operate in?
Adagio Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
RDUSRadius Recycling Inc
US$ 27,902
(104,26%)
8,53M
BONBon Natural Life Ltd
US$ 1,40
(90,29%)
84M
SUNESUNation Energy Inc
US$ 0,5213
(62,96%)
513,96M
WHLRLWheeler Real Estate Investment Trust Inc
US$ 255,00
(39,80%)
222
AAOIApplied Optoelectronics Inc
US$ 22,105
(39,29%)
17,01M
GLSTUGlobal Star Acquisition Inc
US$ 2,00
(-69,23%)
421
CURRCurrenc Group Inc
US$ 2,03
(-41,33%)
1,42M
ADTXAditxt Inc
US$ 0,0201
(-39,82%)
240,2M
HEPAHepion Pharmaceuticals Inc
US$ 0,0228
(-39,68%)
161,52M
WKSPWorksport Ltd
US$ 0,36205
(-35,45%)
4,96M
SUNESUNation Energy Inc
US$ 0,5213
(62,96%)
513,96M
NVDANVIDIA Corporation
US$ 121,67
(5,27%)
277,56M
ADTXAditxt Inc
US$ 0,0201
(-39,82%)
240,2M
HEPAHepion Pharmaceuticals Inc
US$ 0,0228
(-39,68%)
161,52M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 9,225
(7,64%)
160,21M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
ADGI
Adagio Therapeutics
NASDAQI
HWN
Settle ISE FX New Zealan...
NYSE
BSAQ.U
Black Spade Acquisition
USOTC
ISFFF
ISS (PK)
NASDAQ
EDUC
Educational Development
COIN
ERNUSD
@EthernityChain $ERN Token
NASDAQ
CDRO
Codere Online Luxembourg
LSE
KSK
Ksk Power Ventur
BOV
MRSA-DEB72B0
Mrs Logistica
TG
FWF
Flowers Foods
TG
MCHN
Invesco Markets II
COIN
WXTEUR
Wirex Token
COIN
UBTUSD
UniBright
ASX
KFE
Kogi Iron
NASDAQ
SGHL
Signal Hill Acquisition
NYSE
EOCW.U
Elliott Opportunity II
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces